HOME >> MEDICINE >> NEWS
Rutgers research shows caffeine may prevent skin cancer

NEW BRUNSWICK/PISCATAWAY, N.J. Treating the skin with caffeine has been shown to prevent skin cancer in laboratory studies conducted in the Susan Lehman Cullman Laboratory for Cancer Research at Rutgers, The State University of New Jersey.

"It is not a sun-screening effect, but it's something more than that it's a biological effect," said Allan Conney, William M. and Myrle W. Garbe Professor of Cancer and Leukemia Research at Rutgers' Ernest Mario School of Pharmacy. "We may have found a safe and effective way of preventing skin cancer," he said of the discovery, described in the Proceedings of the National Academy of Sciences early online edition, available the week of Aug. 26.

It has been known for a long time that skin cancer is caused predominantly by sunlight. The authors, a group that included Conney and a team of other researchers in the laboratory, explained that sunscreen use has decreased the risk of skin cancers, but there is a need to identify additional approaches for skin-cancer prevention in individuals previously exposed to high-dose levels of sunlight.

The research team, all members of the school's department of chemical biology, studied a special strain of hairless mice that had been exposed to ultraviolet B light twice weekly for 20 weeks. This put the mice at risk for tumor formation and skin cancer. After stopping the exposures, the researchers applied caffeine and epigallocatechin gallate (EGCG), two components of green tea, topically to the skin. Both caffeine and EGCG significantly inhibited cancer formation in the mice.

Although the study showed that most of the positive effects were true for both of these substances, caffeine has the advantage over EGCG. EGCG is chemically less stable, so there could be a problem in applying it topically, Conney said A previous study conducted in the laboratory dealt with caffeine taken orally. The caffeine was provided in the drinking fluid for the mice and the researc
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084
Rutgers, the State University of New Jersey
26-Aug-2002


Page: 1 2

Related medicine news :

1. Rutgers College of Nursing faculty member is funded to develop an interactive computer system
2. Rutgers-Newark researchers link early movement, brain development
3. Rutgers-developed biomaterial drives a technology transfer story toward success
4. Rutgers scientists pinpoint brain cells involved in drug addiction relapse
5. Rutgers researcher: Brains in dyslexic children can be rewired to improve reading skills
6. Rutgers study shows learning ability under stress still strong in Prozac-treated females
7. Rutgers wins funds to create online index of moving brain images
8. Rutgers researcher finds brain connections may reorganize in Parkinsons disease
9. Rutgers announces Robert Wood Johnson Foundation Investigator Awards in Health Policy Research
10. International Thiamine (Vitamin B-1) Conference at Rutgers Newark
11. Rutgers develops virtual reality treatment for hand impairment in chronic stroke patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rutgers research shows caffeine may prevent skin cancer

(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... By Maureen Salamon ... -- Black women undergoing in vitro fertilization (IVF) are only ... using the popular assisted reproduction technique, new research indicates, and ... In the study, about 31 percent of white patients ... black patients. Analyzing more than 4,000 IVF cycles over ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... Oct. 22, 2014  Recently published clinical studies of ... already substantial database of evidence. This data has led ... Stretta therapy for sufferers of refractory GERD. ... supporting Stretta therapy as a safe and effective ... Stretta therapy available to nearly 50 million Americans. The ...
(Date:10/20/2014)... 2014  PneumRx, Inc. ( www.pneumrx.com ), a leader ... of enrollment in their RENEW Study, nearly 3 months ... FDA-approved IDE pivotal trial for the PneumRx RePneu Coil ... was anticipated that the study, which began enrolling subjects ... the end of 2014 to enroll 315 patients.  Instead, ...
(Date:10/20/2014)... ENGLEWOOD, Colo. , Oct. 20, 2014 /PRNewswire/ ... Inc. (NYSE MKT: AMPE), today announced that its ... the clinical and research potential for its novel ... oxidation-reduction potential (ORP) in the body in response ... clinical value of ORP as a clinical marker ...
Breaking Medicine Technology:Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
Cached News: